Please assess the completion status of the following clinical trial:

Trial Title: Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 7.0

Eligibility Criteria:
Inclusion Criteria:~* Brain tumor or CNS inflammatory lesion including stroke or MS~* 5 yrs old or older~* Able to undergo MRI without general anesthesia~* Agree to be followed for 1 month following infusion of Combidex~* Sign a written informed consent~* If female and of child-bearing potential, be postmenopausal, sterile, or be on birth control for 1 month prior to study~* Must have a pre-treatment MRI within 28 days before study~Exclusion Criteria:~* Clinically significant signs of uncal herniation~* Allergy to study drug, Combidex~* Hepatic insufficiency~* Stage IV or V renal insufficiency~* If female, pregnant or lactating~* Require anesthesia for MRI scanning~* Hemachromatosis

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Adults with brain tumor to receive Combidex infusion only
- 2 (Type: ACTIVE_COMPARATOR): Adults with brain tumors to receive Combidex infusion and neurosurgery
- 3 (Type: OTHER): Adults with brain tumors to receive neurosurgery only (NO Combidex)
- 4 (Type: ACTIVE_COMPARATOR): Children with brain tumors to receive Combidex only
- 5 (Type: ACTIVE_COMPARATOR): Children with brain tumors to receive Combidex and neurosurgery
- 6 (Type: OTHER): Children with brain tumors to receive neurosurgery only, NO Combidex
- 7 (Type: ACTIVE_COMPARATOR): Adults with Inflammatory lesions (stroke or MS) to receive Combidex only

Based on this trial design, predict the completion outcome and termination type (if applicable).